SkinBioTherapeutics plc - Balanço Patrimonial (Annual)

SkinBioTherapeutics plc
GB ˙ AIM ˙ GB00BF33H870
£ 9,75 0.00 (0.00%)
2026-04-01
PREÇO DA AÇÃO

Fintel for iPhone

Continue researching SBTX in the Fintel app

Follow this stock, explore its data, and keep your research close on your iPhone.

Get the app
Balanço Patrimonial (Annual)
Balance sheet values are snapshots as of the period end date.

O Balanço Patrimonial de SkinBioTherapeutics plc mostra os saldos das contas da empresa em pontos no tempo. Os dados do Balanço Patrimonial incluem Ativos, Ativos Circulantes, Ativos Fixos, Propriedade, Planta e Equipamento (PPE), Inventário, Intangíveis, Passivos, Passivos Circulantes, Dívida, Obrigações de Arrendamento Mercantil, Ações Ordinárias, Lucros Retidos, Ações do Tesouro e Patrimônio dos Acionistas.

Balance Sheet Trends (Annual)
Unit: 1,000,000 | Currency: GBP
Positive Change
Negative Change

Todos os números são vezes 1,000,000 exceto unidades por ação.

Balanço Patrimonial (Annual)
Financial Metric 2022
06-30
2023
06-30
2024
06-30
2025
06-30
Dinheiro 2 1 1 5
Change (%) (Change percent compared to previous period.) — -27.32 -38.95 496.75
Ativos Correntes 2 2 2 7
Change (%) (Change percent compared to previous period.) — -26.23 -2.87 325.28
Ativos 3 3 5 12
Change (%) (Change percent compared to previous period.) — -15.91 101.02 132.51
Responsabilidades 1 1 2 3
Change (%) (Change percent compared to previous period.) — -1.68 274.61 20.55
Equidade 2 2 3 9
Change (%) (Change percent compared to previous period.) — -19.41 48.87 217.15
Passivos e Patrimônio Líquido 3 3 5 12
Change (%) (Change percent compared to previous period.) — -15.91 101.02 132.51

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista